4-Aza-2,3-dehydro-4-deoxypodophyllotoxins: Simple Aza-podophyllotoxin analogues possessing potent cytotoxicity

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 4, 2000, Pages 315-317

  Hitotsuyanagi, Yukio ^a   Fukuyo, Masamoto ^a   Tsuda, Kyoko ^a   Kobayashi, Masatsugu ^a   Ozeki, Akira ^a   Itokawa, Hideji ^a   Takeya, Koichi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AZA 2,3 DEHYDRO 4 DEOXYPODOPHYLLOTOXIN; DEOXYPODOPHYLLOTOXIN; DRUG ANALOG; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPARATIVE STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; LEUKEMIA CELL; LEUKEMIA P 388; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYTOTOXINS; INHIBITORY CONCENTRATION 50; KERATOLYTIC AGENTS; MODELS, MOLECULAR; PODOPHYLLOTOXIN; QUINOLINES; QUINOLONES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0034696048     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00693-9     Document Type: Article

References (15)

1. Jardine, I. In Anticancer Agents Based on Natural Product Models; Cassady, J. M.; Dourous, J. D., Eds.; Academic Press: New York, 1980; pp 319-351.
2. Ayres, D. C.; Loike, J. D. In Lignans: Chemical, Biological and Clinical Properties; Cambridge University Press: Cambridge, 1990; pp 85-95.
3. For a review, see: Ramos, A. C.; Peláez-Lamamié de Clairac, R.; Medarde, M. Heterocycles 1999, 51, 1443.
4. Terada T., Fujimoto K., Nomura M., Yamashita J., Wierzba K., Kobunai T., Takeda S., Minami Y., Yoshida K., Yamaguchi H., Yamada Y. Chem. Pharm. Bull. 41:1993;907.
5. Van Vliet D.S., Lee K.H. Tetrahedron Lett. 40:1999;2259.
6. Zhu X.K., Guan J., Tachibana Y., Bastow K.F., Cho S.J., Cheng H.H., Cheng Y.C., Gurwith M., Lee K.H. J. Med. Chem. 42:1999;2441.
7. Ward, R. S. Synthesis, 1992, 719.
8. Hitotsuyanagi, Y.; Kobayashi, M.; Fukuyo, M.; Takeya, K.; Itokawa, H. Tetrahedron Lett. 1997, 38, 8295. New compounds 2b, 2g and 2h were prepared according to the method described therein. 2b: Y. 68%, mp 284-286 °C; 2g: Y. 96%, mp 280-282 °C; 2h: Y. 95%, mp >300 °C.
9. Andersen, K. V.; Buchardt, O.; Hansen, H. F.; Jensen, R. B.; Larsen, S. J. Chem. Soc., Perkin Trans. 2 1990, 1871.
10. Mohamadi F., Richards N.G.J., Guida W.C., Liskamp R., Caufield C., Chang G., Hendrickson T., Still W.C. J. Comput. Chem. 11:1990;440.
11. Pettit G.R., Cragg G.M., Suffness M.I., Gust D., Boettner F.E., Williams M., Saenz-Renauld J.A., Brown P., Schmidt J.M., Ellis P.D. J. Org. Chem. 49:1984;4258.
12. Joseph H., Gleye J., Moulis C., Mensah L.J., Roussakis C., Gratas C. J. Nat. Prod. 51:1988;599.
13. A similar tendency in activity was also observed for related compounds. Deoxypodophyllotoxin cyclic ether, where the lactone carbonyl group of 4-deoxypodophyllotoxin was substituted by a methylene unit, was 8-11 times more cytotoxic than the 4-deoxypodophyllotoxin analogue having a cyclopentane ring D structure. Gensler, W. J.; Murthy, C. D.; Trammel, M. H. J. Med. Chem. 1977, 20, 635; Loike, J. D.; Brewer, C. F.; Sternlicht, H.; Gensler, W. J.; Horwitz, S. B. Cancer Res. 1978, 38, 2688.
14. A similar tendency in activity was also observed for related compounds. Deoxypodophyllotoxin cyclic ether, where the lactone carbonyl group of 4-deoxypodophyllotoxin was substituted by a methylene unit, was 8-11 times more cytotoxic than the 4-deoxypodophyllotoxin analogue having a cyclopentane ring D structure. Gensler, W. J.; Murthy, C. D.; Trammel, M. H. J. Med. Chem. 1977, 20, 635; Loike, J. D.; Brewer, C. F.; Sternlicht, H.; Gensler, W. J.; Horwitz, S. B. Cancer Res. 1978, 38, 2688.
15. Tomioka K., Kubota Y., Koga K. Tetrahedron. 49:1993;1891.